AAAAAA

   
Results: 1-11 |
Results: 11
Treatment of meningococcal purpura fulminans
Authors: Leclerc, F Noizet, O Dorkenoo, A Cremer, R Leteurtre, S Sadik, A Fourier, C
Citation: F. Leclerc et al., Treatment of meningococcal purpura fulminans, ARCH PED, 8, 2001, pp. 677S-688S
Purpura fulminans and coxsackie B-2 co-infection
Authors: Fourier, C Noizet, O Thumerelle, C Dewilde, A Vaksmann, G Leclerc, F
Citation: C. Fourier et al., Purpura fulminans and coxsackie B-2 co-infection, PRESSE MED, 30(32), 2001, pp. 1589-1591
Can generic scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of presumed meningococcal septic shock in children?
Authors: Leteurtre, S Leclerc, F Martinot, A Cremer, R Fourier, C Sadik, A Grandbastien, B
Citation: S. Leteurtre et al., Can generic scores (Pediatric Risk of Mortality and Pediatric Index of Mortality) replace specific scores in predicting the outcome of presumed meningococcal septic shock in children?, CRIT CARE M, 29(6), 2001, pp. 1239-1246
Outcome in meningococcemia: A relationship between quantity and quality?
Authors: Leclerc, F Leteurtre, S Noizet, O Cremer, R Fourier, C Sadik, A
Citation: F. Leclerc et al., Outcome in meningococcemia: A relationship between quantity and quality?, CRIT CARE M, 29(10), 2001, pp. 2040-2040
Upper airway obstruction.
Authors: Leclerc, F Leteurtre, S Fayoux, P Martinot, A Dorkenoo, A Sadik, A Cremer, B Fourier, C
Citation: F. Leclerc et al., Upper airway obstruction., ARCH PED, 7, 2000, pp. 14S-20S
Do new strategies in meningococcemia produce better outcomes?
Authors: Leclerc, F Leteurtre, S Cremer, R Fourier, C Sadik, A
Citation: F. Leclerc et al., Do new strategies in meningococcemia produce better outcomes?, CRIT CARE M, 28(9), 2000, pp. S60-S63
Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock
Authors: Leclerc, F Cremer, R Leteurtre, S Martinot, A Fourier, C
Citation: F. Leclerc et al., Protein C concentrate and recombinant tissue plasminogen activator in meningococcal septic shock, CRIT CARE M, 28(5), 2000, pp. 1694-1696
Impact of immunization against Haemophilus influenzae on the incidence of invasive Haemophilus influenzae infections in the Nord-Pas-de-Calais area.
Authors: Dumonceaux, A Leteurtre, S Martinot, A Cremer, R Fourier, C Hue, V Leclerc, F
Citation: A. Dumonceaux et al., Impact of immunization against Haemophilus influenzae on the incidence of invasive Haemophilus influenzae infections in the Nord-Pas-de-Calais area., ARCH PED, 6(6), 1999, pp. 617-624
Are there specific haemostatic abnormalities in children surviving septic shock with purpura and having skin necrosis or limb ischaemia that need skin grafts or limb amputations?
Authors: Cremer, R Leclerc, F Jude, B Sadik, A Leteurtre, S Fourier, C Martinot, A Diependaele, JF
Citation: R. Cremer et al., Are there specific haemostatic abnormalities in children surviving septic shock with purpura and having skin necrosis or limb ischaemia that need skin grafts or limb amputations?, EUR J PED, 158(2), 1999, pp. 127-132
Fibronectin and meningococcal disease
Authors: Leclerc, F Cremer, R Leteurtre, S Martinot, A Fourier, C
Citation: F. Leclerc et al., Fibronectin and meningococcal disease, EUR J PED, 158(1), 1999, pp. 81-81
Septic shock in children. Definition, epidemiology and management.
Authors: Cremer, R Leteurtre, S Dorkenoo, A Fourier, C Sadik, A Leclerc, F
Citation: R. Cremer et al., Septic shock in children. Definition, epidemiology and management., ANN PEDIAT, 46(4), 1999, pp. 266-276
Risultati: 1-11 |